Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

Similar articles for PubMed (Select 2695130)

1.

Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.

Baumhackl U, Bizière K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M.

Br J Psychiatry Suppl. 1989 Oct;(6):78-83.

PMID:
2695130
2.

Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.

Baldwin DS, Green M, Montgomery SA.

Int Clin Psychopharmacol. 2014 Nov;29(6):339-43. doi: 10.1097/YIC.0000000000000042.

PMID:
24859491
3.

A double-blind evaluation of alprazolam and imipramine in the treatment of major depression.

Murthy RS, Chatterjee S, Sriram TG, Shah LP, Parikh R, Elavia S, Munjal GC, Nehru R, Ramachandran V, Nirmala G, Raghavan KS, Kumar V.

Indian J Psychiatry. 1991 Apr;33(2):104-7.

4.

Multicentric efficacy study of centpropazine and imipramine in depressed patients.

Srivastava JS, Asthana OP, Singh H, Agarwal AK, Shah LP, Sharma KC, Gopinath PS, Srimal RC.

Indian J Psychiatry. 1999 Jul;41(3):249-53.

5.

Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients.

Avasthi A, Kulhara P, Singh G, Sharma R, Kaur RP.

Indian J Psychiatry. 2005 Apr;47(2):84-8. doi: 10.4103/0019-5545.55951.

7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.

Lepola U, Arató M, Zhu Y, Austin C.

J Clin Psychiatry. 2003 Jun;64(6):654-62.

PMID:
12823079
10.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

PMID:
12595913
12.

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial.

Silverstone T.

Acta Psychiatr Scand. 2001 Aug;104(2):104-9.

PMID:
11473503
13.

Open comparative randomised study of moclobemide versus amitriptyline in major depressive illness (DSM IIIR) in Nigeria.

Ononye F, Sijuola OA, Chukwuani CM, Mume OC, Makanjuola RO.

West Afr J Med. 2000 Apr-Jun;19(2):148-53.

PMID:
11070752
14.

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM.

J Clin Psychiatry. 2000 Apr;61(4):276-81.

PMID:
10830148
15.

A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.

Søgaard J, Lane R, Latimer P, Behnke K, Christiansen PE, Nielsen B, Ravindran AV, Reesal RT, Goodwin DP.

J Psychopharmacol. 1999 Dec;13(4):406-14.

PMID:
10667618
16.

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.

Katona C, Bercoff E, Chiu E, Tack P, Versiani M, Woelk H.

J Affect Disord. 1999 Oct;55(2-3):203-13.

PMID:
10628889
17.
18.

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.

Krüger MB, Dahl AA.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 1:S19-24.

PMID:
10361962
19.

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.

Tiller JW, Bouwer C, Behnke K.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 1:S7-10.

PMID:
10361960
20.

Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studies.

Delini-Stula A, Baier D, Kohnen R, Laux G, Philipp M, Scholz HJ.

Pharmacopsychiatry. 1999 Mar;32(2):61-7.

PMID:
10333164
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk